[go: up one dir, main page]

CL2017000872A1 - Compositions and methods for the inhibition of the gene expression of hao1 (hydroxy acid oxidase 1 (glycolate oxidase) - Google Patents

Compositions and methods for the inhibition of the gene expression of hao1 (hydroxy acid oxidase 1 (glycolate oxidase)

Info

Publication number
CL2017000872A1
CL2017000872A1 CL2017000872A CL2017000872A CL2017000872A1 CL 2017000872 A1 CL2017000872 A1 CL 2017000872A1 CL 2017000872 A CL2017000872 A CL 2017000872A CL 2017000872 A CL2017000872 A CL 2017000872A CL 2017000872 A1 CL2017000872 A1 CL 2017000872A1
Authority
CL
Chile
Prior art keywords
oxidase
methods
hao1
inhibition
compositions
Prior art date
Application number
CL2017000872A
Other languages
Spanish (es)
Inventor
Brian Bettencourt
Kevin Fitzgerald
William Querbes
Abigail Liebow
David V Erbe
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Publication of CL2017000872A1 publication Critical patent/CL2017000872A1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<p>LA INVENCIÓN SE REFIERE A AGENTES DE ARNi, POR EJEMPLO, AGENTES DE ARNi BICATENARLOS, QUE SE DIRIGEN AL GEN HAO1 Y MÉTODOS DE USO DE TALES AGENTES DE ARNi PARA INHIBIR LA EXPRESIÓN DE HAO1 Y MÉTODOS DE TRATAMIENTO DE SUJETOS QUE TIENEN, POR EJEMPLO, PH1.</p><p> THE INVENTION REFERS TO ARNi AGENTS, FOR EXAMPLE, ARNi AGENTS BICATENAROS, THAT ARE DIRECTED TO THE HAO1 GENE AND METHODS OF USE OF SUCH ARNI AGENTS TO INHIBIT THE EXPRESSION OF HAO1 AND METHODS OF SUBJECT TREATMENT, FOR EXAMPLE, PH1. </p>

CL2017000872A 2014-09-04 2017-04-10 Compositions and methods for the inhibition of the gene expression of hao1 (hydroxy acid oxidase 1 (glycolate oxidase) CL2017000872A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462214602P 2014-09-04 2014-09-04
US201462062751P 2014-10-10 2014-10-10
US201562147976P 2015-04-15 2015-04-15

Publications (1)

Publication Number Publication Date
CL2017000872A1 true CL2017000872A1 (en) 2018-01-12

Family

ID=61147176

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000872A CL2017000872A1 (en) 2014-09-04 2017-04-10 Compositions and methods for the inhibition of the gene expression of hao1 (hydroxy acid oxidase 1 (glycolate oxidase)

Country Status (1)

Country Link
CL (1) CL2017000872A1 (en)

Similar Documents

Publication Publication Date Title
UY36357A (en) COMPOSITIONS AND METHODS FOR THE INHIBITION OF HAO1 GENE EXPRESSION (OXIDASE HYDROXYACYDE 1 (OXIDASE GLYCOLATE))
CY1124215T1 (en) MK2 INHIBITORS AND THEIR USES
MX2022009148A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES.
BR112019007806A2 (en) multiphase buccal composition for the release of active agents for buccal treatment
UY37036A (en) INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK
CL2017003142A1 (en) Compositions comprising bacterial strains
CL2018000198A1 (en) Compositions of transthyretin (ttr) arni and methods for use for the treatment or prevention of diseases associated with ttr
CL2018000108A1 (en) Antibody molecules that bind to cd22
MX2017008698A (en) MULTI-SUPPLEMENT COMPOSITIONS.
MX373290B (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS.
PT3562486T (en) USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION
UY37134A (en) HETEROARILE COMPOUNDS AND COMPOSITIONS THAT CONTAIN USEFUL AS PAD4 INHIBITORS
MX2020011104A (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE.
CU20190006A7 (en) COMPOSITIONS TO INHIBIT MASP-3
BR112017023161A2 (en) obeticolic acid compositions and methods of use
CL2016003263A1 (en) Sterochemically enriched compositions for the release of nucleic acids.
MX2016010675A (en) CONDENSED COMPOUNDS OF [1,4] DIAZEPIN AS INHIBITORS OF AUTOTAXIN PRODUCTION (ATX) AND LISOPHOSPHYTIDIC ACID (LPA).
EA201790266A1 (en) INDOLS FOR USE IN INFECTIONS CAUSED BY THE FLU VIRUS
EA201692526A1 (en) SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS
DOP2016000073A (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GEN ALAS1
MX2017004808A (en) Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis.
MA43650B1 (en) Formulations/compositions comprising a btk inhibitor
TN2018000351A1 (en) Oxaborole esters and uses thereof
DOP2018000066A (en) USEFUL COMPOUNDS TO INHIBIT ROR-GAMMA-T
CL2017000484A1 (en) Azetidinyloxyphenylpyrrolidine compounds